You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Dow

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

When do Amlodipine Besylate And Atorvastatin Calcium patents expire, and when can generic versions of Amlodipine Besylate And Atorvastatin Calcium launch?

Amlodipine Besylate And Atorvastatin Calcium is a drug marketed by Apotex, Dr Reddys, Mylan, and Zydus Pharms. and is included in four NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.

Summary for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Drug patent expirations by year for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Recent Clinical Trials for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Dr. Reddy's Laboratories LimitedPhase 1

See all AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM clinical trials

US Patents and Regulatory Information for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 207762-011 Jan 11, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 207762-002 Jan 11, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 200465-009 Nov 29, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 207762-003 Jan 11, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 200465-010 Nov 29, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKinsey
Baxter
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.